Literature DB >> 17454170

Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus.

Alev E Altinova1, Fusun Toruner, Nuray Bozkurt, Neslihan Bukan, Ayhan Karakoc, Ilhan Yetkin, Goksun Ayvaz, Nuri Cakir, Metin Arslan.   

Abstract

Adiponectin and tumor necrosis factor-alpha (TNF-alpha) have been implicated in insulin resistance and diabetes mellitus (DM). In the present study we investigated levels of adiponectin and TNF-alpha and their relationships with each other and metabolic factors in women with gestational DM (GDM). Thirty-four pregnant women with GDM and 31 pregnant women with normal glucose tolerance (NGT) were included in the study. Plasma adiponectin levels were lower in GDM than in NGT (36.9 +/- 6.7 vs. 61.3 +/- 13.0 ng/ml, p = 0.028). Serum TNF-alpha levels were increased in GDM compared with NGT (20.5 +/- 2.4 vs. 14.0 +/- 1.5 pg/ml, p = 0.042). After adjustment for pre-pregnancy and current body mass index (BMI), adiponectin levels correlated negatively with insulin resistance by homeostasis model assessment-insulin resistance (HOMA-IR) and 0-h and 1-h glucose both at glucose challenge test and oral glucose tolerance test in GDM. Adiponectin levels were correlated only with very low-density lipoprotein cholesterol and triglyceride levels in NGT. TNF-alpha levels were correlated with glycated hemoglobin in GDM. There was a significant positive correlation between TNF-alpha levels and pre-pregnancy and current BMI in GDM as well as NGT. HOMA-IR for adiponectin and pre-pregnancy BMI for TNF-alpha remained as significant determinants in multiple regression analyses. In conclusion, these data suggest that reduced adiponectin and increased TNF-alpha may be involved in the pathogenesis of GDM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454170     DOI: 10.1080/09513590701227960

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  18 in total

1.  L-methionine placental uptake: characterization and modulation in gestational diabetes mellitus.

Authors:  João R Araújo; Ana Correia-Branco; Carla Ramalho; Pedro Gonçalves; Maria J Pinho; Elisa Keating; Fátima Martel
Journal:  Reprod Sci       Date:  2013-05-07       Impact factor: 3.060

Review 2.  Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Errol R Norwitz; Pål Aukrust; Thor Ueland
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

3.  Roles of Inflammation and Depression in the Development of Gestational Diabetes.

Authors:  Thalia K Robakis; Linn Aasly; Katherine Ellie Williams; Claire Clark; Natalie Rasgon
Journal:  Curr Behav Neurosci Rep       Date:  2017-10-28

4.  Maternal visfatin concentration in normal pregnancy.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

5.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

6.  The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy.

Authors:  Ramamani Arumugam; Eric Horowitz; Danhong Lu; J Jason Collier; Sarah Ronnebaum; Don Fleenor; Michael Freemark
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

7.  Interleukin 10 and tumor necrosis factor-alpha in pregnancy: aspects of interest in clinical obstetrics.

Authors:  Jusciele Brogin Moreli; Ana Maria Cirino Ruocco; Joice Monaliza Vernini; Marilza Vieira Cunha Rudge; Iracema Mattos Paranhos Calderon
Journal:  ISRN Obstet Gynecol       Date:  2012-02-20

Review 8.  Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.

Authors:  Sally K Abell; Barbora De Courten; Jacqueline A Boyle; Helena J Teede
Journal:  Int J Mol Sci       Date:  2015-06-11       Impact factor: 5.923

9.  Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans.

Authors:  So-Young Kim; Vanessa Sy; Takako Araki; Nicole Babushkin; Diana Huang; Doris Tan; Emilia Liao; George Liu; Stephen Wan; Leonid Poretsky; Donna Seto-Young
Journal:  J Diabetes       Date:  2014-02-26       Impact factor: 4.006

Review 10.  Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Jie Xu; Yan Hong Zhao; Yun Ping Chen; Xiao Lei Yuan; Jiao Wang; Hui Zhu; Chun Mei Lu
Journal:  ScientificWorldJournal       Date:  2014-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.